Sygnature Discovery Competitors and Similar CompaniesClear all

Sygnature Discovery's competitors and similar companies include Pfizer, Regeneron Pharmaceuticals, Quantum Hi-Tech (China) Biological and Fortrea.

	Sygnature Discovery Sygnature Discovery is a company that specializes in drug discovery.	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.	Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.	Quantum Hi-Tech (China) Biological Quantum Hi-Tech (China) Biological is a biotechnology company.	Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
Founding Date	Founding Date 2004	Founding Date 1849	Founding Date 1988	Founding Date 2000	Founding Date 2023
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech chemicals clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Nottingham, GB HQ Cambridge, US South San Francisco, US	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more	Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more	Locations Guang Zhou Shi, CN HQ	Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more
Employees	Employees 669	Employees 81,0008% decrease	Employees 15,1068% increase	Employees 1,814	Employees 19,000
Valuation ($)	Valuation ($) N/A	Valuation ($) 163.9 b	Valuation ($) 102.2 b	Valuation ($) N/A	Valuation ($) 1.6 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $62.6b (FY, 2025)	Revenue (est.) $14.3b (FY, 2025)	Revenue (est.) ¥1.1b (FY, 2025)	Revenue (est.) $2.7b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $16.1b (FY, 2025)	Cost of goods N/A	Cost of goods ¥810m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $46.5b (FY, 2025)	Gross profit N/A	Gross profit ¥320.9m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income $7.8b (FY, 2025)	Net income $4.5b (FY, 2025)	Net income ¥13.6m (FY, 2025)	Net income ($986.2m) (FY, 2025)
Operating ⚠
Countries	Countries N/A	Countries 200 (FY, 2024)	Countries N/A	Countries N/A	Countries 90 (Jul, 2023)